A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain
Public ClinicalTrials.gov record NCT00991172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Subcutaneously Administered REGN475 in Patients With Sciatic Pain
Study identification
- NCT ID
- NCT00991172
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Enrollment
- 159 participants
Conditions and interventions
Conditions
Interventions
- REGN475 Drug
- Placebo Injection Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2009
- Primary completion
- Apr 30, 2010
- Completion
- Apr 30, 2010
- Last update posted
- Dec 7, 2011
2009 – 2010
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Regeneron Investigational Site | Birmingham | Alabama | — | — |
| Regeneron Investigational Site | Mobile | Alabama | — | — |
| Regeneron Investigational Site | Peoria | Arizona | — | — |
| Regeneron Investigational Site | Anaheim | California | — | — |
| Regeneron Investigational Site | Beverly Hills | California | — | — |
| Regeneron Investigational Site | National City | California | — | — |
| Regeneron Investigational Site | Santa Ana | California | — | — |
| Regeneron Investigational Site | Milford | Connecticut | — | — |
| Regeneron Investigational Site | Stamford | Connecticut | — | — |
| Regeneron Investigational Site | Clearwater | Florida | — | — |
| Regeneron Investigational Site | Hallandale | Florida | — | — |
| Regeneron Investigational Site | St. Petersburg | Florida | — | — |
| Regeneron Investigational Site | Tampa | Florida | — | — |
| Regeneron Investigational Site | West Palm Beach | Florida | — | — |
| Regeneron Investigational Site | Atlanta | Georgia | — | — |
| Regeneron Investigational Site | Sandy Springs | Georgia | — | — |
| Regeneron Investigational Site | Overland Park | Kansas | — | — |
| Regeneron Investigational Site | Rockville | Maryland | — | — |
| Regeneron Investigational Site | Kansas City | Missouri | — | — |
| Regeneron Investigational Site | Albuquerque | New Mexico | — | — |
| Regeneron Investigational Site | Raleigh | North Carolina | — | — |
| Regeneron Investigational Site | Cincinnati | Ohio | — | — |
| Regeneron Investigational Site | Duncansville | Pennsylvania | — | — |
| Regeneron Investigational Site | Tyrone | Pennsylvania | — | — |
| Regeneron Investigational Site | Warwick | Rhode Island | — | — |
| Regeneron Investigational Site | Greer | South Carolina | — | — |
| Regeneron Investigational Site | Memphis | Tennessee | — | — |
| Regeneron Investigational Site | El Paso | Texas | — | — |
| Regeneron Investigational Site | San Antonio | Texas | — | — |
| Regeneron Invesitgational Site | West Jordan | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00991172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 7, 2011 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00991172 live on ClinicalTrials.gov.